Development roadmap for subcutaneous delivery of high dose biologics - high concentration formulation, analytical comparability and patient preference considerations for large volume devices

已完结 10 由 oxygen 发布于 2026/6/10 11:27:20

DOI:10.1016/j.xphs.2025.103914
作者：Indrajit Ghosh , Daniel Miranda , Tanmay A. Kulkarni , Suyash Deodhar , Srinivas Tummala , Dilbir Bindra
文献类型：期刊论文
补充材料：只需要正文

Elsevier

Abstract：High dose biologic drug products (DPs) have become a common trend for the treatment of chronic diseases across a wide range of therapeutic areas. While the expectation is to deliver these DP

应助信息

14小时前

yangxiang

5970467e647d11f1859c34735aa3bc31.pdf 已采纳

14小时前

Book学术机器人

2026/6/10 11:27:20 未找到该文献，机器人已退出，请等待人工下载

2026/6/10 11:27:20 Book学术AI机器人收到请求，开始寻找文献

2026/6/10 11:27:20 已向机器人发送请求

14小时前

oxygen 发布求助

上一个求助:其它数据库Naturally Fractured Carbonate Reservoir Characterization: A Case Study of a Mature High-Pour Point Oil Field in Hungary 下一个求助:WileyMultifunctional DNA Hydrogels with Hydrocolloid-Cotton Structure for Regeneration of Diabetic Infectious Wounds